G01N 2333/9108
With definite ec number
Official title: with definite EC number (2.3.2.-)
G01N2333/9108 (With definite ec number) appears on 80 US grants and 141 published applications in this corpus.
Search patents in G01N- Granted patents
- 80
- Published applications
- 141
- Assignees
- 109
- Inventors
- 361
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 2 |
| 2002 | 1 | 0 |
| 2003 | 1 | 2 |
| 2004 | 3 | 3 |
| 2005 | 1 | 2 |
| 2006 | 3 | 2 |
| 2007 | 1 | 2 |
| 2008 | 2 | 2 |
| 2009 | 1 | 5 |
| 2010 | 1 | 5 |
| 2011 | 2 | 4 |
| 2012 | 2 | 5 |
| 2013 | 2 | 4 |
| 2014 | 2 | 4 |
| 2015 | 2 | 9 |
| 2016 | 2 | 4 |
| 2017 | 2 | 13 |
| 2018 | 6 | 7 |
| 2019 | 2 | 3 |
| 2020 | 5 | 7 |
| 2021 | 4 | 11 |
| 2022 | 5 | 11 |
| 2023 | 5 | 9 |
| 2024 | 0 | 9 |
| 2025 | 8 | 9 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Combination of markers for predicting the response to Vx-0018 Sep 2026US 12,728,158 B2Kriptic Pharmaceuticals Limited
- Biological markers in the diagnosis of endometriosis4 Aug 2026US 12,699,103 B2Yeditepe Universitesi
- tTG-DGP biomarkers for monitoring celiac disease30 Jun 2026US 12,669,510 B2Mayo Foundation for Medical Education and Research
- DCIS recurrence and invasive breast cancer2 Dec 2025US 12,487,242 B2Prelude Corporation
- Renal cell populations and uses thereof9 Sep 2025US 12,409,191 B2ProKidney
- Lysine-free ubiquibody variants for long-lived intracellular protein silencing27 Aug 2026US 2026/0250647 A1
- Method of detecting target substance, reagent, and in vitro diagnostic kit20 Aug 2026US 2026/0242844 A1Canon Kabushiki Kaisha
- Protein complexes for proximity-based labeling of intracellular microenvironments16 Jul 2026US 2026/0202414 A1
- FRET Active E2-UBL Conjugates and Uses Thereof2 Jul 2026US 2026/0185137 A1Board of Regents, The University of Texas System
- Therapeutic agent for treating hif-1alpha-mediated diseases by inhibiting arel1 and restoring phd2 activity7 May 2026US 2026/0125685 A1Biochemgen Inc.
Most cited
By later US patents
- Biomarkers and targets for diagnosis, prognosis and management of prostate disease113US 5,972,615 AUrocor, Inc. · 1999
- Biomarkers and targets for diagnosis prognosis and management of prostate disease91US 6,171,796 B2Urocor, Inc. · 2001
- Diagnosis of coeliac disease using a gliadin epitope59US 7,144,569 B1Isis Innovation Limited · 2006
- Pet leash with length-limited elastic section38US 5,873,328 A1999
- Diagnostic and therapeutic epitope, and transgenic plant31US 7,888,460 B2Isis Innovation Limited · 2011